Double-blind comparison of naftifine cream and clotrimazole/betamethasone dipropionate cream in the treatment of tinea pedis.
Smith
E B
EB
Department of Dermatology, University of Texas Medical Branch, Galveston.
Breneman
D L
DL
Griffith
R F
RF
Hebert
A A
AA
Hickman
J G
JG
Maloney
J M
JM
Millikan
L E
LE
Sulica
V I
VI
Dromgoole
S H
SH
Sefton
J
J
D000287:Administration, Topical; D000328:Adult; D000499:Allylamine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage* / Q000009:adverse effects; D000935:Antifungal Agents / Q000008:administration & dosage* / Q000009:adverse effects; D001623:Betamethasone / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D003022:Clotrimazole / Q000008:administration & dosage* / Q000009:adverse effects; D004311:Double-Blind Method; D004338:Drug Combinations; D005260:Female; D005938:Glucocorticoids; D006801:Humans; D008297:Male; D009824:Ointments; D014008:Tinea Pedis / Q000188:drug therapy*
D000893:Anti-Inflammatory Agents; D000935:Antifungal Agents; D004338:Drug Combinations; D005938:Glucocorticoids; D009824:Ointments; D000499:Allylamine; C029178:naftifine; C011175:betamethasone-17,21-dipropionate; D001623:Betamethasone; D003022:Clotrimazole